CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes
-
- Hidestrand
- 作成者
収録刊行物
-
- Drug Metab. Dispos.
-
Drug Metab. Dispos. 29 1480-, 2001